Lawson Software, Inc. (NASDAQ:LWSN) reported financial results for its second quarter of fiscal year 2011, which ended Nov. 30, 2010. As reported under generally accepted accounting principles (GAAP), revenues were $187.5 million with operating income of $20.5 million and net income of $12 million, or diluted earnings per share (EPS) of $0.07. These results compare to second quarter of fiscal year 2010 GAAP revenues of $184.4 million with operating income of $13.2 million and net income of $2.8 million, or EPS of $0.02.
Lawson Software, Inc. provides enterprise software, services, and support. The company offers a range of software applications and industry-specific solutions that help its customers in enhancing their business processes.
Power3 Medical Products, Inc. (PWRM.OB) is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
The company management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer's and Parkinson's, to name a few.
Power3 plans to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with PWRM remaining as the surviving company. The acquisition of Rozetta-Cell is expected to be completed in February 2011.
Rozetta-Cell is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. The company has a robust intellectual property portfolio and has created numerous products for adult stem cell therapy that are ready for market globally. Rozetta-Cell also has several collaborations in process through which it is partnering with industry-leading adult stem cell research companies and adult stem cell vendors.
For more information about this company please visit http://www.power3medical.com
GreenHouse Holdings, Inc. (OTCQB:GRHU) is a San Diego, California based integrator of some of the world’s most innovative environmental, public safety, infrastructure technologies. GreenHouse provides systems that are financially sound and sustainable to residential, commercial, industrial and government markets around the globe. GreenHouse provides energy-efficiency products, energy management systems, eco-friendly infrastructure, scalable waste-to-fuel bio-fuel and closed loop systems, as well as other proprietary technologies and products that are utilized to provide a greener and safer future for millions of people.
GRHU reported that it has been engaged to implement Southern California Edison’s (SCE) Automated Demand Response (Auto-DR) program for two industrial customers. The customers include Apogee Containers, Inc. and MGE UPS, LLC.
GreenHouse estimates that the projects will generate $400,000 in revenue for GreenHouse, based upon approximately 1,300 kW or 1.3 MW of electricity demand reduction and infrastructure improvements from the engagements. GreenHouse is a qualified service provider of SCE’s Auto-DR program, providing site assessment, feasibility studies, project development, engineering, and installation of enabling technologies including complete processing of all utility documents.
For more information about this company please visit http://www.greenhouseintl.com/
PCTEL, Inc. (NASDAQ:PCTI) announced that they have launched a new joint venture – PCTEL Secure LLC – that will provide engineering services and design platforms that enable secure applications. PCTEL will initially own a majority interest in PCTEL Secure and has the right to acquire the rest of the company over the next three years. “PCTEL Secure will leverage unique capabilities within Eclipse Design and the outstanding resources that PCTEL has in RF, DSP, and system software,” said Marty Singer, PCTEL’s Chairman and CEO. “PCTEL Secure will provide services and deliver fully integrated products to our existing OEM customers, wireless distributors, and specialized Value Added Resellers,” added Singer.
PCTEL, Inc. provides propagation and optimization solutions for the wireless industry. The company designs and develops software-based radios for wireless network optimization; and develops and distributes antenna solutions.
Matrixx Initiatives, Inc. (NASDAQ:MTXX) reported that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"), relating to the previously announced acquisition of all outstanding shares of common stock of the Company by affiliates of H.I.G. Accordingly, the condition with respect to the expiration of the applicable waiting periods under the HSR Act has been satisfied.
Matrixx Initiatives, Inc., through its subsidiaries, develops, markets, and sells over-the-counter healthcare products in the United States. It offers Zicam Cold Remedy to reduce the duration of the common cold; Zicam Zavors, a coated chewable product; and Zicam Liqui-loz, a liquid center lozenge.
CRWESelect, a stock highlight publication is pleased to alert investors of stocks on the move.
Sign Up for our Free Stock Newsletter at http://www.crweselect.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received ten thousand dollars in cash and anticipates another ten thousand dollars in cash from the company for 60 days of advertisement services for Green House Holdings, Inc. (GRHU). In addition to the cash, Crown Equity Holdings Inc. (CRWE.OB) also anticipates receiving 20,000 shares of 144 restricted stocks from a third party. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).